Abstract
A randomized, double-blind, crossover study of response to delivery of albuterol aerosol, 200 μg, via Inhal-Aid to 18 asthmatic children 3-6 years of age disclosed highly significant increases in peak expiratory flow rate 5 and 20 min after treatment as compared with placebo. Increases in heart rate after inhalation of albuterol did not differ significantly from those that followed placebo. Use of the Inhal-Aid permits effective delivery of a bronchodilator aerosol from a metered dose inhaler to young children.
Get full access to this article
View all access options for this article.